https://www.indianpharmapost.com/margin-disappointment-continues-for-lupin-in-q1fy23-prabhudas-lilladher-127982022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/herthena-lung02-phase-3-trial-of-patritumab-deruxtecan-initiated-in-patients-with-egfr-mutated-metastatic-non-small-cell-lung-cancer-128062022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/enhertu-approved-in-the-us-as-the-first-her2-directed-for-low-metastatic-breast-cancer-128052022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/jb-pharma-records-revenue-growth-of-30-in-q1-fy23-128042022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/health-tech-startup-clinikk-opens-18-primary-care-centers-across-bengaluru-and-hyderabad-128032022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/indraprastha-medical-corporation-posts-q1-fy23-pat-at-rs-2028-cr-128022022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/lyka-labs-swings-back-to-profit-in-q1fy23-128012022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/briefs-zydus-lifesciences-and-kimia-biosciences-128002022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/fortis-healthcare-posts-q1-fy2023-consolidated-pat-at-rs-12225-cr-127992022-08-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/ube-to-buy-api-corp-from-mitsubishi-chemical-128072022-08-09T00:00:00+05:30always0.9